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Clinical Images
Presentations of Cutaneous Disease in Various Skin
Pigmentations: Plaque Psoriasis
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Description

Recent studies estimate that more than 8 million Americans have psoriasis. The prevalence
of psoriasis in African Americans is 1.5% compared to 3.6% of Caucasians. Psoriasis is likely
to be underdiagnosed among African Americans and other individuals with darker pigmented skin due to variations in clinical presentation in addition to disease distribution and
severity. We present images of psoriasis vulgaris in a variety of Fitzpatrick skin types. Differences in the biology of skin pigmentation may explain the clinical masking of erythema in
darker-skinned individuals. Recognition of this important difference will help clinicians utilize
additional clues to identify and diagnose this entity correctly.
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com)
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Introduction

Psoriasis is likely to be underdiagnosed among
African Americans and other individuals with
skin of color due to variations in clinical presentation.1 Additionally, disease distribution and
severity may contribute to decreased rates of
diagnosis.1 Differences in skin pigmentation can
be described using the Fitzpatrick scale (Figure 1). Psoriasis is commonly associated with
comorbidities such as chronic kidney disease,

I
Always burns,
never tans

II
Mostly burns,
rarely tans

III

inflammatory bowel disease, hepatic disease,
certain malignancies, and/or mood disorders.2,3
It is also a risk factor for cardiometabolic disease.2,3 The ability to accurately diagnose psoriasis is critical to appropriately screen these patients for the above comorbidities and provide
treatment. Additional background information
on the Fitzpatrick scale and a description of
the classification of skin types are discussed in
further detail in the article “Presentations of

V

IV

Sometimes burns, Rarely burns,
often tans
mostly tans

VI

Almost never burns,
always tans

Never burns,
always tans

Figure 1. The Fitzpatrick scale provides a classification system for an individual’s skin type based
on the ability to burn and/or tan when exposed to ultraviolet light. It is used to approximate the
degree of skin pigmentation.
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Figure 2. Fitzpatrick type II (mostly burns, rarely tans) skin demonstrating plaque psoriasis in 2
separate patients. The photo on the left depicts plaque psoriasis on the abdomen of a Fitzpatrick
type II female. There are multiple erythematous, or pink or red-colored skin, plaques (raised, >1
cm), and papules (raised, <1 cm). The lesions are well demarcated (distinctly different from the
adjacent normal skin where the border is readily identified). The photo on the right depicts plaque
psoriasis on the elbow of a male with Fitzpatrick type II skin. The lesions are erythematous and
well-demarcated with a micaceous (silvery, white, thick) scale.
Cutaneous Disease in Various Skin Pigmentations: An Introduction”.4

Clinical Images

Plaque psoriasis typically presents as sharply demarcated, erythematous, scaly plaques.
Commonly affected areas include the scalp,
trunk, gluteal fold, and extensor surfaces such

as the elbows and knees.2 Psoriasis can have
many different scale types, including micaceous, thick, and thin.
Figure 2 exemplifies the bright red erythematous nature of the plaques in a patient with
Fitzpatrick skin type II (mostly burns, rarely
tans). Also depicted are the varying degrees

Figure 3. Fitzpatrick type III (sometimes burns, often tans) skin demonstrating plaque psoriasis
involving the trunk and upper and lower extremities. The lesions have bright red erythema. This is
in contrast to the erythema observed in Fitzpatrick type V (almost never burns, always tans) skin.
The photo on the left depicts a large bright red plaque (raised, >1 cm) on the right lateral thigh.
There is an overlying micaceous scale. The photo in the middle depicts two large plaques (raised,
>1 cm) on the lateral arm. As mentioned above, there is a micaceous scale, and the lesions are well
demarcated (distinctly different from the adjacent normal skin where the border is readily identified). The photo on the right depicts a large plaque (raised, >1 cm) on the back with multiple satellite papules (raised, <1 cm) on the periphery.
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Figure 4. Fitzpatrick type IV (rarely burns, mostly tans) skin demonstrating plaque psoriasis on
the abdomen. The lesions are similar in morphology to those in Figure 1, with a notable difference,
the erythema is more salmon-colored. The left depicts multiple papules (raised, <1 cm) coalescing
or forming into plaques (raised, >1 cm). The lesions are well-demarcated (distinctly different from
the adjacent normal skin where the border is readily identified). On the right is a close-up of the
micaceous scale on the psoriatic plaques.
of thickness of scale. On the left are multiple
plaques with thick white scales, and on the
right side, micaceous scales are depicted. The
term micaceous refers to the mica stone with a
silvery-white lamellated scale.
Figure 3 depicts a classic example of the appearance of micaceous, thick, and thin scale in
Fitzpatrick skin type III (sometimes burns, often tans). The left picture depicts a large bright
red plaque with an overlying thick white scale
on the right lateral thigh. The image in the middle is an example of a micaceous scale on the
left forearm of the same patient. The image
on the right depicts a large plaque on the back
with a thin overlying scale.
Figure 4 exemplifies the salmon-colored, sharply demarcated plaques with an overlying silvery
scale in patients with Fitzpatrick skin type IV
(rarely burns, mostly tans). Well-demarcated
refers to the distinct boundaries of the lesion
that are clearly defined.

Figure 5 depicts multiple large violaceous
plaques and papules with well-demarcated
borders and white scale on the trunk and buttocks of a patient with Fitzpatrick skin type V
(almost never burns, always tans). The erythema in darker skin tones is often less conspicuous and may appear violaceous, violet in
color, or hyperpigmented, appearing brown to
dark brown. When assessing disease burden in
patients, it is essential to consider that psoriatic plaques in patients with skin of color often
resolve with either hypo- or hyperpigmented
patches. The depigmentation may take anywhere from 6 to 12 months or more to resolve.
Figure 6 provides a classic example of the
appearance of a micaceous scale in a Fitzpatrick skin type V (almost never burns, always
tans). There are large, violaceous papules and
plaques on the thighs, extensor surface of the
knees, and lower legs with thick, white micaceous scale overlying the plaques on the bilateral
knees.
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Figure 5. Fitzpatrick type V (almost never burns, always tans) skin demonstrating plaque psoriasis involving the trunk, buttocks, and upper extremities. The erythema is dark red to violaceous in
color. The photo on the left depicts the generalized distribution of the psoriatic plaques. The photo in the middle is a close-up visualizing the violaceous erythema seen surrounding each papule
(raised, <1 cm) and plaque (raised, >1 cm). There is an overlying white, silvery scale.
The photo on the right shows the papules (raised, <1 cm) coalescing, or forming, into plaques
(raised, >1 cm). The lesions are also involving his umbilicus, a common location for psoriasis
Figure 7 shows classic examples of psoriasis
affecting the scalp in Fitzpatrick skin types
II (mostly burns, rarely tans), III (sometimes
burns, often tans), and V (almost never burns,
always tans). Of note, the picture on the far
right depicts an example of festooning. The
origin of the term “festooning” refers to “a
garland or wreath hanging in a curve, which is

used in decoration.” This can be visualized in the
photo as the plaque suspended from the scalp,
extending onto the forehead.
Survey results from national psoriasis experts
found that African American patients experienced a higher degree of dyspigmentation (41%
of responders) but a lower amount of erythema (24% of responders).5 African Americans

Figure 6. Fitzpatrick type V (almost never burns, always tans) skin showing plaque psoriasis on
the thighs, extensor surface of the knees, and lower legs. This is a classic presentation for psoriasis because the extensor surfaces of the extremities are a common location for this disease. As
seen in Figure 3, the erythema is a dark red to violaceous color. There is an overlying micaceous
scale.
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Figure 7. Three photos show plaque psoriasis affecting the scalp. The photo on the left is plaque
psoriasis on the occipital scalp in Fitzpatrick type II (mostly burns, rarely tans) skin. There is visible
erythema on the edge of the plaque (raised, > 1cm) with a thick micaceous scale overlying the
lesion. The photo in the middle is plaque psoriasis on the left postauricular and occipital scalp in
Fitzpatrick type III (sometimes burns, often tans) skin. The erythema is a bright red color on the
periphery of the plaque (raised, >1 cm). There is a micaceous scale seen overlying the lesion.
The photo on the right is plaque psoriasis on the forehead in Fitzpatrick type V (almost never
burns, always tans) skin. The erythema is dark red to violaceous in color. The plaque (raised, >2
cm) is festooning on the forehead. Festooning refers to the appearance of the plaque wrapping
like a garland across the top of the forehead.
have also been reported to have more extensive body surface area (BSA) involvement. A
survey found that African Americans reported 3
to 10% BSA involvement compared to only 1 to
2% BSA reported by Caucasian patients.6

Discussion

The most current studies estimate that more
than 8 million Americans have psoriasis. Psoriasis has a bimodal age distribution from 18
to 39 and 50 to 69, with similar occurrences in
men and women.7 Psoriasis may present at an
earlier age due to genetic factors. For example,
the human leukocyte antigen (HLA)-C*06 allele
is associated with an earlier age of onset of
psoriasis.8
The prevalence of psoriasis in African Americans is 1.5% compared to 3.6% of Caucasians.9
The numbers may be misleading as a national
study analyzing NHANES data from 2003 to
2004 showed racial/ethnic disparities in access
to a dermatologist have been reported in the
United States, and undiagnosed psoriasis was
more prevalent among African Americans.10
The pathogenesis of psoriasis is complex; it
is continually undergoing further research.
Overactivation of certain parts of the adaptive
immune system is the main component of its
pathogenesis.2,11 Overactivation of the adaptive
immune system leads to leads to many downstream effects of psoriasis, including keratinocyte proliferation and infiltration of immune

cells into lesional skin.2,11
Psoriasis is a chronic skin disease associated
with multiple systemic comorbidities. These
include coronary atherosclerotic plaques,
increased risk of myocardial infarction, depression, anxiety, and/or suicidal ideation.2,3 Additionally, approximately one-third of patients
with psoriasis will develop psoriatic arthritis at
some point during their lifetime.12
The differential diagnosis of psoriasis includes
atopic dermatitis, seborrheic dermatitis, lichen
planus, and cutaneous T-cell lymphoma. Atopic
dermatitis can also affect a large body surface
area. However, pruritis is typically more persistent, and these lesions lack the well-demarcated morphology of psoriatic plaques. Seborrheic dermatitis is also ill-defined and occurs
in a seborrheic distribution (scalp, eyebrows,
nasolabial folds, upper back and chest, axillae,
etc.). Lichen planus and cutaneous T-cell lymphoma also lack the micaceous scale observed
in psoriasis. Lichen planus presents with purple,
polygonal, pruritic, flat-topped papules and
plaques with overlying grayish-white streaks
called Wickham’s striae. Cutaneous T-cell lymphoma consists of patches and thin plaques
with fine scales favoring sun-protected areas.

Informed Consent

Written informed consent was obtained from
the patients for their anonymized information
to be published in this article.
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